Tag: RA Capital
Estuary exits stealth with $93M to reverse a common kidney disease
The Biogen-alum startup aims to do what tolvaptan cannot, halting or reversing cyst growth in autosomal dominant polycystic kidney disease…
The Biogen-alum startup aims to do what tolvaptan cannot, halting or reversing cyst growth in autosomal dominant polycystic kidney disease…